Gram-negative urinary tract infections and increasing isolation of ESBL-producing or ceftazidime-resistant strains in children: Results from a single-centre survey;Infezioni delle vie urinarie da batteri gram-negativi e aumento di ceppi esbl-produttori in pediatria. Risultati di uno studio osservazionale monocentrico

Infezioni in Medicina

Volumn 21, Issue 1, 2013, Pages 29-33

  Giardino, Stefano ^a   Bandettini, Roberto ^b   Perotti, Maddalena ^b   Piaggio, Giorgio ^d   Degl'Innocenti, Ludovica ^d   Sacco, Rosanna ^e   Ciucci, Antonella ^e   Caviglia, Ilaria ^c   Barabino, Paola ^f   Ginocchio, Francesca ^c   Losurdo, Giuseppe ^c   Haupt, Riccardo ^g   Castagnola, Elio ^c  

^a Department of Haematology and Oncology   (Italy)

^b Laboratory of Microbiology   (Italy)

^c Infectious Diseases   (Italy)

^d Department of Pediatrics   (Italy)

^e Istituto Giannina Gaslini ^*

^f Istituto Giannina Gaslini   (Italy)

^g G GASLINI INSTITUTE   (Italy)

Author keywords

Ceftazidime resistance; Extended spectrum beta lactamase; Paediatrics; Urinary tract infections

Indexed keywords

CEFTAZIDIME; EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATION; GRAM NEGATIVE BACTERIUM; HEALTH SURVEY; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INCIDENCE; INFECTION CONTROL; MAJOR CLINICAL STUDY; MINIMUM INHIBITORY CONCENTRATION; NEPHROLOGY; PROSPECTIVE STUDY; URINALYSIS; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CEFTAZIDIME; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HEALTH SURVEYS; HOSPITALS, PEDIATRIC; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; ITALY; MICROBIAL SENSITIVITY TESTS; PROSPECTIVE STUDIES; RISK FACTORS; URINARY TRACT INFECTIONS;

EID: 84875587249     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Wald E.R. Cystitis and pyelonephritis. In: Feigin RD, Cherry JD, Demmler-Harrison G, Kaplan SL, eds. Feigin & Cherry's Textbook of pediatric infectious diseases. Philadelphia, PA: Saunders Elsevier. 554-68, 2009.
2. Campobasso P. Antibiotic prophylaxys in pediatric surgery of genito-urinary abnormalities. Infezioni in Medicina. 2, 88-92, 2002.
3. Edlund C., Nord C. Effect on the human normal microflora of oral antibiotics for treatment of urinary tract infections J. Antimicrob. Chemother. 46, 41-48, 2000.
4. Meier S., Weber R., Zbinden R., Ruef C., Hasse B. Extended-spectrum β-lactamase-producing Gramnegative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 39, 333-340, 2011.
5. Kao C.C., Liu M.F., Lin C.F. Antimicrobial susceptibility and multiplex PCR screening of AmpC genes from isolates of Enterobacter cloacae, Citrobacter freundii, and Serratia marcescens. J. Microbiol. Immunol. Infect. 43, 180-187, 2010.
6. Bassetti M., Repetto E. Diagnostic and therapeutic management of Gram negative infections. Infezioni in Medicina 16 (Suppl. 2), 22-29, 2008.
7. Diamante P., Camporese A. Evaluation of Vitek 2 performance for identifying extended spectrum betalactamases in Enterobacteriaceae "other than Escherichia coli, Proteus mirabilis and Klebsiella spp. Infezioni in Medicina 4, 216-226, 2006.
8. th Informational Supplement (June 2010 Update) CLSI document M100-S20-U. Wayne, PA, USA: CLSI, 2010; 2010.
9. Leclercq R., Cantón R., Brown D.F., et al. EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. 19 (2), 141-160, 2013.
10. Swinscow T.D.V., revised by Campbell MJ. Statistics at Square One. London: BMJ Publishing Group; 1997.
11. Peters C.A., Skoog S.J., Arant B.S.J., et al. Summary of the AUA Guideline on Management of Primary Vesicoureteral Reflux in Children. J. Urol. 184, 1134-1144, 2010.
12. Zegers B.S., SWinkler-Seinstra P.L., Uiterwaal C.S., et al. Urinary tract infections in children with spina bifida: an inventory of 41 European centers. Pediatr. Nephrol. 24, 783-388, 2009.
13. Bellissima P, Amato R. Incidence of extended spectrum beta-lactamase (ESBL)-producing Enterobacteria in the area of Caltagirone (Sicily). Infezioni in Medicina. 2, 108-112, 2004.
14. Gattuso G., Tomasoni D., Palvarini L., et al. Epidemiology of ESBL-positive Enterobacteriaceae in Mantova hospital (Italy). Infezioni in Medicina. 3, 164-168, 2009.
15. Nicolle E. Update in adult urinary tract infection. Curr. Infect. Dis. Rep. 13, 552-560, 2011.
16. Rodríguez-Baño J., Alcalá J.C., Cisneros J.M., et al. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch. Intern. Med. 168 (17), 1897-1902, 2008.
17. Grandesso S., Sapino B., Mazzucato S., Alessandrini R., Solinas M., Gion M. Study on in-vitro susceptibility of ESBL-positive Escherichia coli isolated from urine specimens. Infezioni in Medicina. 3, 162-168, 2010.
18. Laupland K.B., Church D.L., Vidakovich J., Mucenski M., Pitout J.D. Community-onset extended-spectrum lactamase (ESBL) producing E. coli: importance of international travel. J. Infect. 57, 441-448, 2008.
19. Vijayakumar M., Kanitkar M., Nammalwar B.R., Bagga A., for the Indian Society of Pediatric Nephrology. Revised statement on management of urinary tract infections. Indian. Pediatr. 48, 709-717, 2011.